[Skip to Content]
[Skip to Content Landing]

Patient Safety: Eradicating Adverse Drug Events - Prevention 2019

The US Department of Health and Human Services is transforming the ways in which adverse drug events (ADEs) are identified and addressed by improvements and innovations in health care service delivery. The HHS Office of Disease Prevention and Health Promotion leads these efforts through The National Action Plan for ADE Prevention. As part of the overall approach, FDA's Safe Use Initiative (Safe Use) seeks to reduce preventable harm from drugs by soliciting and funding projects that develop innovative methods to create, facilitate, and encourage research in safe medication use. We will provide an overview of the National Action Plan and its implementers, as well as FDA's research proposal submission process for Safe Use along with examples of funded research.

Outcome Objectives:
• Describe broadly the intentions and content of the National Action Plan for Adverse Drug Event Prevention
• Demonstrate utilization of the Management of Anticoagulation in the Peri-Procedural period (MAPPP) app which aligns with the National Action Plan
• Describe required and desirable attributes of the Broad Agency Announcement (BAA) research proposals to the FDA's Safe Use Initiative for potential funding
• Describe the two-stage process for Safe Use BAA submissions and assessments


Learn now
American College of Preventive Medicine

American College of Preventive Medicine (ACPM) is dedicated to improving the health and quality of life of individuals, families, communities and populations through disease prevention and health promotion. Learn more

Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Close